Deferred Registration: Quotient Sciences Code: QSC303955
This study is a Phase 1 clinical trial running in the UK by Quotient Sciences. Phase 1 trials are the very first step in testing a potential new medicine in humans. Their main goal is to check safety, look for side effects, and see how the body processes the drug. This trial is looking for healthy men and women aged between 18 and 55. At this moment, full details about the specific medicine being tested are not public. Under UK trial regulations, early-stage trials can have 'deferred registration'. This allows researchers to keep commercial and scientific details private for a limited time. Volunteers who take part are looked after by a dedicated medical team in a specialist clinic. All participants are monitored very closely throughout the study to make sure they remain safe and well.
At a glance
What is this study about?
Before any new medicine can be given to patients who are unwell, doctors must first check that it is safe to use. These early tests are known as Phase 1 clinical trials. They usually involve a small group of healthy volunteers rather than people with medical conditions. This helps doctors understand how the medicine behaves in a healthy body without other illnesses or treatments getting in the way.
You might notice that specific details about this study, such as the exact medicine or condition it might treat in the future, are listed as 'deferred'. In the UK, early-stage studies can delay publishing their full details for a limited time to protect scientific discoveries. Even though these details are not yet public, the trial has still gone through strict ethical reviews and safety approvals before being allowed to start.
Healthy volunteer trials like this one are a crucial part of medical research. Without them, new treatments for serious diseases could never be developed. By taking part, volunteers help scientists discover whether a medicine is safe enough to move on to larger studies in patients who need it.
Key takeaways
- Phase 1 trial testing the safety of an early-stage medicine in healthy adults.
- Open to men and women aged between 18 and 55 years old.
- Full details are temporarily deferred under UK research regulations.
- Participants do not receive direct medical benefits, but help advance science.
- All volunteers are closely monitored by doctors in a specialist clinic.
Who may be eligible?
This trial is open to men and women aged between 18 and 55 who are in good general health. Because this is a Phase 1 study, researchers are specifically looking for healthy volunteers rather than people who have a specific illness.
Because the full trial details are currently deferred, the complete list of criteria has not yet been published. However, Phase 1 studies typically require people who do not take regular prescription medicines, have normal blood test results, and have no significant past medical issues.
If you are interested in taking part, the research clinic will carry out thorough health checks to see if the trial is right for you. They will explain all the specific medical requirements before you agree to anything.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- I am between 18 and 55 years old.
- I consider myself to be in good general health.
- I do not take regular prescription medicines for chronic illnesses.
- I am willing to undergo health checks, including blood tests and heart scans.
- I am available to visit or stay at a research clinic for the required dates.
What does participation involve?
Taking part usually starts with a screening visit at a specialist research clinic. A doctor will check your medical history, take your blood pressure, do blood and urine tests, and perform a heart trace (ECG). If you are suitable, you will be invited to join the study. This may involve staying at the clinic for a few days or attending several short visits. While there, you will receive the study medicine, and staff will check your health regularly. After the study medicine leaves your body, you will have a final follow-up visit to make sure you are well. The whole process typically lasts from a few weeks to a couple of months.
Potential risks and benefits
Locations (1)
- Quotient SciencesApproximateNottingham, England
Common questions
What is a Phase 1 clinical trial?
It is the earliest stage of human testing for a new medicine. It focuses on safety, finding out how the body processes the medicine and checking for side effects.
Why are some trial details hidden or deferred?
UK rules allow companies to keep early scientific details private for a limited time. This protects intellectual property while the first tests are being carried out.
Will I get paid for taking part?
Most Phase 1 healthy volunteer studies offer payment to compensate you for your time, travel, and any inconvenience, but you should check directly with the clinic.
What does being a 'healthy volunteer' mean?
It means you do not have any major ongoing illnesses, you generally take no regular prescription medicines, and your health checks show you are fit and well.
Can I leave the study if I change my mind?
Yes. You can leave the study at any point, before or after taking the medicine, and you do not need to give a reason.
How to find out more
Skyhawk Study Doctor
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.